348 related articles for article (PubMed ID: 23165378)
1. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
[TBL] [Abstract][Full Text] [Related]
2. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
[TBL] [Abstract][Full Text] [Related]
3. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
5. Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Lee YS; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
Acta Otolaryngol; 2014 Oct; 134(10):1062-70. PubMed ID: 25220728
[TBL] [Abstract][Full Text] [Related]
6. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
[TBL] [Abstract][Full Text] [Related]
7. Predictive accuracy of first post-treatment PET/CT in HPV-related oropharyngeal squamous cell carcinoma.
Koshkareva Y; Branstetter BF; Gaughan JP; Ferris RL
Laryngoscope; 2014 Aug; 124(8):1843-7. PubMed ID: 24474646
[TBL] [Abstract][Full Text] [Related]
8. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
[TBL] [Abstract][Full Text] [Related]
10. Lessons from a standardized program using PET-CT to avoid neck dissection after primary radiotherapy for N2 squamous cell carcinoma of the oropharynx.
Hitchcock KE; Amdur RJ; Mendenhall WM; Werning JW; Drane WE; Mancuso AA
Oral Oncol; 2015 Sep; 51(9):870-4. PubMed ID: 26164415
[TBL] [Abstract][Full Text] [Related]
11. Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
Kendi AT; Magliocca K; Corey A; Nickleach DC; Galt J; Higgins K; Beitler JJ; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Clin Nucl Med; 2015 Mar; 40(3):e196-200. PubMed ID: 25608156
[TBL] [Abstract][Full Text] [Related]
12. Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Lee J; Davis SJ; Amin SN; Rohde SL; Kim YJ
Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1133-1139. PubMed ID: 36453776
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y
Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445
[TBL] [Abstract][Full Text] [Related]
14. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
15. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
[TBL] [Abstract][Full Text] [Related]
16. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer.
Gourin CG; Williams HT; Seabolt WN; Herdman AV; Howington JW; Terris DJ
Laryngoscope; 2006 May; 116(5):705-10. PubMed ID: 16652075
[TBL] [Abstract][Full Text] [Related]
17. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
[TBL] [Abstract][Full Text] [Related]
18. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
19. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
20. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]